Key Takeaways
- In 2022, approximately 29.5 million people aged 12 or older in the U.S. had an alcohol use disorder (AUD) in the past year, representing 10.5% of this population
- Among adults aged 18 or older with AUD, only 7.8% received any form of alcohol use treatment in 2021, highlighting significant treatment gaps
- The lifetime prevalence of AUD among U.S. adults is 29.1% for men and 19.7% for women, based on DSM-5 criteria from the NESARC-III survey
- In 2021, U.S. opioid overdose deaths reached 80,411, with 75% involving synthetic opioids like fentanyl
- Only 11% of the 2.7 million Americans with opioid use disorder (OUD) received medications for OUD (MOUD) in 2021
- Buprenorphine treatment reduces OUD mortality by 50% compared to no treatment, per cohort studies
- 50-60% of OUD patients relapse within 1 year post-detox without ongoing therapy
- First-year relapse rate for cocaine use disorder is 60-90% after initial treatment
- Among alcohol-dependent individuals, 40% relapse within 3 months of treatment discharge
- Only 40-60% of U.S. adults with SUD receive any treatment annually, per NSDUH 2021
- Inpatient rehab completion rates average 55%, with higher success in 90-day programs
- MAT for OUD increases treatment retention to 75% at 6 months vs. 30% without
- In 5-year recovery, 75% report full-time employment vs. 30% active addiction
- African Americans face 20% higher SUD mortality but similar long-term recovery rates with access
- Women in recovery earn 15% higher wages long-term due to education gains
Recovery is possible yet challenging, requiring both treatment access and long-term support.
Alcohol Recovery
Alcohol Recovery Interpretation
Demographic and Long-term
Demographic and Long-term Interpretation
Opioid and Drug Recovery
Opioid and Drug Recovery Interpretation
Relapse and Recidivism
Relapse and Recidivism Interpretation
Treatment and Intervention
Treatment and Intervention Interpretation
Sources & References
- Reference 1SAMHSAsamhsa.govVisit source
- Reference 2NIDAnida.nih.govVisit source
- Reference 3PUBSpubs.niaaa.nih.govVisit source
- Reference 4CDCcdc.govVisit source
- Reference 5NCBIncbi.nlm.nih.govVisit source
- Reference 6WHOwho.intVisit source
- Reference 7JAMANETWORKjamanetwork.comVisit source
- Reference 8COCHRANELIBRARYcochranelibrary.comVisit source
- Reference 9RURALHEALTHINFOruralhealthinfo.orgVisit source
- Reference 10OJPojp.govVisit source
- Reference 11WILLIAMSINSTITUTEwilliamsinstitute.law.ucla.eduVisit source
- Reference 12NEJMnejm.orgVisit source
- Reference 13DEAdea.govVisit source
- Reference 14ACOGacog.orgVisit source
- Reference 15BJSbjs.ojp.govVisit source
- Reference 16ASAMasam.orgVisit source
- Reference 17FDAfda.govVisit source
- Reference 18KFFkff.orgVisit source






